These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30576679)

  • 1. Erythropoietin in tumor angiogenesis.
    Annese T; Tamma R; Ruggieri S; Ribatti D
    Exp Cell Res; 2019 Jan; 374(2):266-273. PubMed ID: 30576679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.
    Okazaki T; Ebihara S; Asada M; Yamanda S; Niu K; Arai H
    Neoplasia; 2008 Sep; 10(9):932-9. PubMed ID: 18714393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
    Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
    Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and Its Angiogenic Activity.
    Kimáková P; Solár P; Solárová Z; Komel R; Debeljak N
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic effects of erythropoietin.
    Ribatti D
    Int Rev Cell Mol Biol; 2012; 299():199-234. PubMed ID: 22959304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
    Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO
    PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
    Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y
    Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma.
    Ribatti D; Poliani PL; Longo V; Mangieri D; Nico B; Vacca A
    Histopathology; 2007 Apr; 50(5):636-41. PubMed ID: 17394500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
    Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
    Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin in cancer: an update.
    Tóvári J; Pirker R; Tímár J; Ostoros G; Kovács G; Döme B
    Curr Mol Med; 2008 Sep; 8(6):481-91. PubMed ID: 18781955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.
    Ribatti D; Marzullo A; Gentile A; Longo V; Nico B; Vacca A; Dammacco F
    Histopathology; 2007 Apr; 50(5):591-6. PubMed ID: 17394495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and cancer: the protective role of erythropoietin.
    Buemi M; Caccamo C; Nostro L; Cavallaro E; Floccari F; Grasso G
    Med Res Rev; 2005 Mar; 25(2):245-59. PubMed ID: 15389732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epo is involved in angiogenesis in human glioma.
    Nico B; Annese T; Guidolin D; Finato N; Crivellato E; Ribatti D
    J Neurooncol; 2011 Mar; 102(1):51-8. PubMed ID: 20614229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin regulates tumour growth of human malignancies.
    Yasuda Y; Fujita Y; Matsuo T; Koinuma S; Hara S; Tazaki A; Onozaki M; Hashimoto M; Musha T; Ogawa K; Fujita H; Nakamura Y; Shiozaki H; Utsumi H
    Carcinogenesis; 2003 Jun; 24(6):1021-9. PubMed ID: 12807756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin and co.: intrinsic structure and functional disorder.
    Uversky VN; Redwan EM
    Mol Biosyst; 2016 Dec; 13(1):56-72. PubMed ID: 27833947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
    Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
    J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.